In a cross-sectional screen of 72 U.S. banking services stocks that prioritized return on equity, valuation, dividend yield and size, five institutions passed every filter. Among them, two names emerge as the clearest candidates when balancing fundamental strength and current market pricing: East West Bancorp (EWBC) and Zions Bancorporation (ZION).
The defensibility matrix
The screen produced a compact group of five banks that clear the defined hurdles. Their key metrics are presented for side-by-side comparison in the table below.
| Bank | Fair Value Upside | P/E (LTM) | P/Book | ROE | NI Margin | FCF Yield | Debt/Equity | Piotroski Score | Dividend Yield | Fin. Health Score |
|---|---|---|---|---|---|---|---|---|---|---|
| EWBC | +29.7% | 12.6x | 2.0x | 16.6% | 50.1% | 8.5% | 45% | 7 | 2.4% | 2.90 |
| ZION | +19.6% | 9.0x | 1.4x | 16.3% | 31.8% | 11.5% | 41.7% | 7 | 2.7% | 2.86 |
| SFBS | +27.1% | 15.6x | 2.5x | 17.3% | 54.8% | 7.4% | 81.6% | 6 | 1.7% | 2.89 |
| BOH | +30.7% | 14.6x | 2.0x | 14.6% | 31.4% | 6.5% | 48.7% | 7 | 3.5% | 2.08 |
| SYF | -5.3% | 7.5x | 1.7x | 22.2% | 35.5% | N/A | 108.2% | 6 | 1.7% | 3.34 |
Why EWBC stands out
East West Bancorp presents a compelling combination of margin strength, steady top-line expansion and a conservative capital structure. Its reported net income margin of 50.1% sits well above the regional peer group, where many banks report margins in the 30s. Over the past four fiscal years revenue has increased from $2.16 billion to $2.70 billion without materially increasing leverage; the balance sheet shows a debt-to-equity ratio of 45%.
The Piotroski score of 7 indicates simultaneous improvement across profitability, leverage and operating efficiency measures rather than isolated gains. At the time of the screen the share price was $132.99 against a calculated fair value of $172.42, implying roughly a $40 per share discount from fair value and an upside near +29.7%.
ZION as the value play
Zions Bancorporation occupies the opposite corner of the value-quality spectrum. With a P/E of 9.0x and a P/B of 1.4x, it is the cheapest name among the five by the multiples reported. Its free cash flow yield of 11.5% is the highest in the screened group, signaling substantial cash generation relative to market price.
Zions also reports the most conservative leverage profile of the five, with debt-to-equity at 41.7%. The Piotroski 7 score again suggests that metrics across profitability, leverage and efficiency are showing improvement rather than a single strong line item. Revenue has drifted higher from $3.03 billion three years ago to $3.31 billion today. For investors prioritizing discount and cash yield over the superior margins that characterize EWBC, ZION represents a clear value candidate.
Where defensibility is less clear
Not all members of the five-name cohort are equally free from concerns. BOH has the largest reported fair value upside at +30.7% but carries the lowest financial health score of 2.08. That combination, alongside a 3.5% dividend yield, suggests the market or the screening rules are flagging structural risks that weigh on its health metric.
SYF, despite the highest reported return on equity at 22.2%, is the only name trading above fair value with a reported upside of -5.3%, which removes it from consideration on an overvaluation test. SFBS posts the strongest net income margin at 54.8% but trades at a P/B of 2.5x, a premium that reduces the margin for error.
Bottom line
On the metrics used in the screen, EWBC is the leading candidate for investors seeking defensive fundamentals without paying a valuation premium - exceptional margins, measured leverage, a Piotroski 7 and nearly +30% fair value upside, combined with multi-year revenue growth. ZION is the recommended complementary idea for those who emphasize cash generation and inexpensive multiples. Holding both could provide a balanced exposure across margin quality and discounted cash yield within the banking sector.